Thus, the goal of this investigation was to look into the potential effects of GnT-V in diabetic cardiomyopathy, namely cardiac hypertrophy, as well as the underlying in vivo and in vitro molecular pathways. Here, MGAT5 is linked to cardiac hypertrophy.